XML 35 R24.htm IDEA: XBRL DOCUMENT v3.25.0.1
RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Tables)
9 Months Ended
Mar. 31, 2024
Restatement Of Previously Issued Financial Statements  
Schedule of financial statements by line items
         
   As Reported  Change  As Restated
Indefinite life intangible assets  $44,945,255   $(34,190,000)  $10,755,255 
                
Total other assets  $210,570,510   $(34,190,000)  $176,380,510 
Total assets  $212,279,340   $(34,190,000)  $178,089,340 
Accumulated deficit  $(274,757,816)  $(34,190,000)  $(308,947,816)
Total stockholders’ equity  $168,595,556   $(34,190,000)  $134,405,556 
Total liabilities and stockholders’ equity  $212,279,340   $(34,190,000)  $178,089,340 
Intangible asset impairment  $8,421,000   $34,190,000   $42,611,000 
Total operating expenses for the three months ended March 31, 2024  $17,190,840   $34,190,000   $51,380,840 
Total operating expenses for the nine months ended March 31, 2024  $30,345,029   $34,190,000   $64,535,029 
Loss from operations three months ended March 31, 2024  $(17,190,840)  $(34,190,000)  $(51,380,840)
Loss from operations nine months ended March 31, 2024  $(30,345,029)  $(34,190,000)  $(64,535,029)
Net loss for the three months ended March 31, 2024  $(17,024,414)  $(34,190,000)  $(51,214,414)
Net loss for the nine months ended March 31, 2024  $(30,728,563)  $(34,190,000)  $(64,918,563)
Comprehensive loss for the three months ended March 31, 2024  $(15,963,213)  $(34,190,000)  $(50,153,213)
Comprehensive loss for the nine months ended March 31, 2024  $(29,664,711)  $(34,190,000)  $(63,854,711)
Basic and diluted net loss per share for the three months ended March 31, 2024  $(0.16)  $(0.32)  $(0.48)
Basic and diluted net loss per share for the nine months ended March 31, 2024  $(0.39)  $(0.43)  $(0.82)
Schedule of restatement of previously issued financial statements
         
   As Reported  Change  As Restated
Common stock  $14,750   $343  $15,093 
Additional paid-in capital  $442,304,652   $7,775,313  $450,079,965 
Accumulated deficit  $(308,847,816)  $(7,775,656)  $(316,723,472)
Change in fair value of contingent consideration  $486,500   $(7,774,656)  $(7,289,156)
Net loss for the three months ended March 31, 2024  $(51,214,414 )  $(7,774,656)  $(58,990,070)
Net loss for the nine months ended March 31, 2024  $(64,918,563)  $(7,774,656)  $(72,694,219)
Comprehensive loss for the three months ended March 31, 2024  $(50,152,213)  $(7,774,656)  $(57,928,869)
Comprehensive loss for the nine months ended March 31, 2024  $(63,854,711)  $(7,774,656)  $(71,630,368)
Basic and diluted net loss per share for the three months ended March 31, 2024  $(0.48)  $(0.06)  $(0.54)
Basic and diluted net loss per share for the nine months ended March 31, 2024  $(0.82)  $(0.09)  $(0.91)